Analysts Recommendations Sophiris Bio, Inc. (SPHS)


Sophiris Bio, Inc. (SPHS) reported the earnings of $-0.17/Share in the last quarter where the estimated EPS by analysts was $-0.1/share. The difference between the expected and actual EPS was $-0.07/share, which represents an Earnings surprise of -70%.

Many analysts are providing their Estimated Earnings analysis for Sophiris Bio, Inc. and for the current quarter 3 analysts have projected that the stock could give an Average Earnings estimate of $-0.11/share. These analysts have also projected a Low Estimate of $-0.12/share and a High Estimate of $-0.1/share.

Some buy side analysts are also providing their Analysis on Sophiris Bio, Inc., where 0 analysts have rated the stock as Strong buy, 4 analysts have given a Buy signal, 0 said it’s a HOLD, 0 reported it as Underperform and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. 4 Analysts reported that the Price Target for Sophiris Bio, Inc. might touch $8 high while the Average Price Target and Low price Target is $6.75 and $6 respectively.

To analyze a stock, one should look for Upgrades and Downgrades of a stock. Sophiris Bio, Inc. got Initiated on 13-Mar-17 where investment firm Rodman & Renshaw Initiated the stock to Buy.

Sophiris Bio, Inc. closed its last trading session at $2.58 with the gain of 11.24%. The Market Capitalization of the company stands at 86.44 Million. The Company has 52-week high of $8.55 and 52-week low of $0.8. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 11.98% where SMA50 and SMA200 are 5.28% and -4.95% respectively. The Company Touched its 52-Week High on Jul 26, 2016 and 52-Week Low on May 23, 2016.

The Relative Volume of the company is 4.89 and Average Volume (3 months) is 444.91 million. Sophiris Bio, Inc. P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -95.3%. The Return on Equity (ROE) value stands at -308.3%. While it’s Return on Investment (ROI) value is 0%.

While looking at the Stock’s Performance, Sophiris Bio, Inc. currently shows a Weekly Performance of 12.55%, where Monthly Performance is 9.13%, Quarterly performance is 1.06%, 6 Months performance is -3.04% and yearly performance percentage is 106.47%. Year to Date performance value (YTD perf) value is 2.5%. The Stock currently has a Weekly Volatility of 5.35% and Monthly Volatility of 6.07%.